References
- Aguirre Ghiso JA, Alonso DF, Farias EF, et al (1999). Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur J Biochem, 263, 295-304. https://doi.org/10.1046/j.1432-1327.1999.00507.x
- Burg-Roderfeld M, Roderfeld M, Wagner S, et al (2007). MMP- 9-hemopexin domain hampers adhesion and migration of colorectal cancer cells. Int J Oncol, 30, 985-92.
- Chan SL, Yeo W (2012). Targeted therapy of hepatocellular carcinoma: present and future. J Gastroenterology and Hepatology, 27, 862-72. https://doi.org/10.1111/j.1440-1746.2012.07096.x
- Chung TW, Lee YC, Ko JH, Kim CH (2003). Hepatitis B virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res, 63, 3453-8.
- Dai JZ, Gao J, Li ZF, et al (2011). In vitro and in vivo antitumor activity of scutellaria barbate extract on murine liver cancer. Molecules, 16, 4389-400. https://doi.org/10.3390/molecules16064389
- Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J, 278, 16-27. https://doi.org/10.1111/j.1742-4658.2010.07919.x
- Giannelli G, Bergamini C, Fransvea E, et al (2001). Human hepatocellular carcinoma cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest, 81, 613-27. https://doi.org/10.1038/labinvest.3780270
- Hu XW, Meng D, Fang J (2008). Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Carcinogenesis, 29, 2369-76. https://doi.org/10.1093/carcin/bgn244
- Hwang E, Lee HJ (2006). Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep1 human hepatoma cells. Exp Biol Med, 231, 421-30. https://doi.org/10.1177/153537020623100408
- Jing MJ, Chung FW, Wen L, et al (2005). Antiinflammatory and analgesic activities of the tissue culture of Saussurea involucrata. Biological and Pharmaceutical Bulletin, 28, 1612-4. https://doi.org/10.1248/bpb.28.1612
- Kelloff GJ, Boone CW, Steele V, et al (1994). Progress in cancer chemoprevention: perspectives on agent selection and shortterm clinical intervention trials. Cancer Res, 54, 2015-24.
- Lai KC, Huang ANC, Hsu SC, et al (2010). Benzyl L isothiocyanate (BITC) inhibits migration and invasion of human colon cancer HT29 cells by inhibiting matrix metalloproteinase- 2/-9 and urokinase plasminogen (uPA) through PKC and MAPK signaling pathway. J Agricultural and Food Chemistry, 58, 2935-42. https://doi.org/10.1021/jf9036694
- Lata GM, Ramadasan K, Girija K (1995). Inhibition of lung metastasis in mice induced by B 16FlO melanoma cells by polyphenolic compounds. Cancer Letters, 95, 221-5. https://doi.org/10.1016/0304-3835(95)03887-3
- Li GH, Zhao RC (1989). Studies on pharmacological actions of Saussurea involucrata Kar. et Kir. Acta Pharmacologica Sinica, 15, 368-9.
- Lijun H, Wu Y, Lin L, et al (2011). Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling Pathway. Cancer Science, 102, 219-25. https://doi.org/10.1111/j.1349-7006.2010.01778.x
- Liu, B, Wang G, Yang J, et al (2011). Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PLoS One, 6, 21416. https://doi.org/10.1371/journal.pone.0021416
- Maatta M, Soini Y, Liakka A, Autio-Harmainen H (2000). Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res, 6, 2726-34.
- Mitsunobu M, Toyosaka A, Oriyama T, et al (1996). Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel. Clin Exp Metastasis, 14, 520-9. https://doi.org/10.1007/BF00115112
- Ogata R, Torimura T, Motoaki K, et al (1999). Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum Pathol, 30, 443-50. https://doi.org/10.1016/S0046-8177(99)90121-1
- Roomi MW, Roomi NW, Kalinovsky T, et al (2012). Micronutrient synergy in the fight against Hepatocellular Carcinoma. Cancers, 4, 323-39. https://doi.org/10.3390/cancers4020323
- Sato H, Takino H, Okada Y, et al (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond.), 370, 61-5. https://doi.org/10.1038/370061a0
- Sternlicht MD, Werb Z (2001). How matrix metalloproteinases regulate cell behavior. Annu Res Cell Dev Biol, 17, 465-16.
- Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 9, 541-73. https://doi.org/10.1146/annurev.cb.09.110193.002545
- Tam EM, Moore TR, Butler GS, Overall CM (2004). Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J Biol Chem, 279, 43336-44. https://doi.org/10.1074/jbc.M407186200
- Tan W, Lu J, Huang W, et al (2011). Anti-cancer natural products isolated from Chinese medicinal herbs. Chinese Medicine, 6, 1-15. https://doi.org/10.1186/1749-8546-6-1
- Tanaka SS, Mariko Y, Mori H, et al (1997). Cell-cell contact down-regulates expression of membrane type metalloproteinase-1 (MT1-MMP) in a mouse mammary gland epithelial cell line. Zool. Science (Washington, DC), 14, 95-9.
- Weng CJ, Chau CF, Hsieh YS, et al (2008). Lucidenic acid inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Carcinogenesis, 29, 147-56.
- Yang SF, Chen MK, Hsieh YS, et al (2010) Antimetastatic effects of Terminalia catappa L. on oral cancer via a downregulation of metastasis-associated proteases. Food Chem Toxicol, 48, 1052-8. https://doi.org/10.1016/j.fct.2010.01.019
-
Yeh CB, Hsieh MJ, Hsieh YH, et al (2012). Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-
${\kappa}B$ Activity. PLoS ONE, 7, 31055. https://doi.org/10.1371/journal.pone.0031055 - Yeh, CB, Hsieh MJ, Lin CW, et al (2013). The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation. PLoSOne, 8, 56661. https://doi.org/10.1371/journal.pone.0056661
- Zhang J, Zhang D, Wu GQ, et al (2013). Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis Int, 12, 305-9. https://doi.org/10.1016/S1499-3872(13)60048-X
Cited by
- Anticancer Potential of an Ethanol Extract of Saussurea Involucrata against Hepatic Cancer Cells in vitro vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7527
- Momordica cochinchinensis Seed Extracts Suppress Migration and Invasion of Human Breast Cancer ZR-75-30 Cells Via Down-regulating MMP-2 and MMP-9 vol.15, pp.3, 2014, https://doi.org/10.7314/APJCP.2014.15.3.1105
- Metastatic Inhibitory and Radical Scavenging Efficacies of Saponins Extracted from the Brittle Star (Ophiocoma erinaceus) vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4751
- Viscum Album Var Hot Water Extract Mediates Anti-cancer Effects through G1 Phase Cell Cycle Arrest in SK-Hep1 Human Hepatocarcinoma cells vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6417
- Chemical Constituents of Saussurea involucrata with Anti-Hypoxia Activity vol.52, pp.3, 2016, https://doi.org/10.1007/s10600-016-1681-9
- Actinidia callosa var. callosa suppresses metastatic potential of human hepatoma cell SK-Hep1 by inhibiting matrix metalloproteinase-2 through PI3K/Akt and MAPK signaling pathways vol.59, pp.1, 2018, https://doi.org/10.1186/s40529-017-0216-4